Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.21.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock and Capital in Excess of Par Value, Shares
Common Stock and Capital in Excess of Par Value, Amount
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Total KLA Stockholders' Equity
Total KLA Stockholders' Equity
Cumulative Effect, Period of Adoption, Adjustment
Non- Controlling Interest
Beginning balance (in shares) at Jun. 30, 2019     159,475              
Beginning balance at Jun. 30, 2019 $ 2,677,693     $ 2,017,312 $ 714,825   $ (73,029) $ 2,659,108   $ 18,585
Increase (Decrease) in Stockholders' Equity                    
Net income attributable to KLA 346,525       346,525     346,525    
Other comprehensive income 1,174           1,174 1,174    
Net loss attributable to non-controlling interest (129)                 (129)
Net issuance under employee stock plans (in shares)     281              
Net issuance under employee stock plans (23,423)     (23,423)       (23,423)    
Repurchase of common stock (in shares)     (1,659)              
Repurchase of common stock (228,496)     (20,988) (207,508)     (228,496)    
Cash dividends and dividend equivalents declared (120,669)       (120,669)     (120,669)    
Stock-based compensation expense 26,944     26,944       26,944    
Ending balance (in shares) at Sep. 30, 2019     158,097              
Ending balance at Sep. 30, 2019 2,679,619     1,999,845 733,173   (71,855) 2,661,163   18,456
Beginning balance (in shares) at Jun. 30, 2019     159,475              
Beginning balance at Jun. 30, 2019 2,677,693     2,017,312 714,825   (73,029) 2,659,108   18,585
Increase (Decrease) in Stockholders' Equity                    
Net income attributable to KLA 805,532                  
Other comprehensive income (15,265)                  
Net loss attributable to non-controlling interest (822)                  
Repurchase of common stock (in shares)     (5,326)              
Repurchase of common stock (821,084)                  
Ending balance (in shares) at Mar. 31, 2020     155,049              
Ending balance at Mar. 31, 2020 2,325,196     2,019,071 376,656   (88,294) 2,307,433   17,763
Beginning balance (in shares) at Jun. 30, 2019     159,475              
Beginning balance at Jun. 30, 2019 2,677,693     2,017,312 714,825   (73,029) 2,659,108   18,585
Increase (Decrease) in Stockholders' Equity                    
Accounting Standards Update [Extensible List]   us-gaap:AccountingStandardsUpdate201613Member                
Ending balance (in shares) at Jun. 30, 2020     155,461              
Ending balance at Jun. 30, 2020 2,681,010 $ (5,530)   2,090,268 654,930 $ (5,530) (79,774) 2,665,424 $ (5,530) 15,586
Beginning balance (in shares) at Sep. 30, 2019     158,097              
Beginning balance at Sep. 30, 2019 2,679,619     1,999,845 733,173   (71,855) 2,661,163   18,456
Increase (Decrease) in Stockholders' Equity                    
Net income attributable to KLA 380,555       380,555     380,555    
Other comprehensive income 5,097           5,097 5,097    
Net loss attributable to non-controlling interest (250)                 (250)
Net issuance under employee stock plans (in shares)     442              
Net issuance under employee stock plans 12,262     12,262       12,262    
Repurchase of common stock (in shares)     (1,690)              
Repurchase of common stock (280,593)     (21,375) (259,218)     (280,593)    
Cash dividends and dividend equivalents declared (135,509)       (135,509)     (135,509)    
Stock-based compensation expense 26,789     26,789       26,789    
Ending balance (in shares) at Dec. 31, 2019     156,849              
Ending balance at Dec. 31, 2019 2,687,970     2,017,521 719,001   (66,758) 2,669,764   18,206
Increase (Decrease) in Stockholders' Equity                    
Net income attributable to KLA 78,452       78,452     78,452    
Other comprehensive income (21,536)           (21,536) (21,536)    
Net loss attributable to non-controlling interest (443)                 (443)
Net issuance under employee stock plans (in shares)     177              
Net issuance under employee stock plans (4,284)     (4,284)       (4,284)    
Repurchase of common stock (in shares)     (1,977)              
Repurchase of common stock (311,995)     (25,436) (286,559)     (311,995)    
Cash dividends and dividend equivalents declared (134,238)       (134,238)     (134,238)    
Stock-based compensation expense 31,270     31,270       31,270    
Ending balance (in shares) at Mar. 31, 2020     155,049              
Ending balance at Mar. 31, 2020 2,325,196     2,019,071 376,656   (88,294) 2,307,433   17,763
Beginning balance (in shares) at Jun. 30, 2020     155,461              
Beginning balance at Jun. 30, 2020 2,681,010 (5,530)   2,090,268 654,930 (5,530) (79,774) 2,665,424 (5,530) 15,586
Increase (Decrease) in Stockholders' Equity                    
Net income attributable to KLA 420,567       420,567     420,567    
Other comprehensive income 328           328 328    
Net loss attributable to non-controlling interest (425)                 (425)
Net issuance under employee stock plans (in shares)     172              
Net issuance under employee stock plans (25,145)     (25,145)       (25,145)    
Repurchase of common stock (in shares)     (1,027)              
Repurchase of common stock (193,897)     (19,400) (174,497)     (193,897)    
Cash dividends and dividend equivalents declared (141,555)       (141,555)     (141,555)    
Stock-based compensation expense 26,992     26,992       26,992    
Ending balance (in shares) at Sep. 30, 2020     154,606              
Ending balance at Sep. 30, 2020 2,762,345     2,072,715 753,915   (79,446) 2,747,184   15,161
Beginning balance (in shares) at Jun. 30, 2020     155,461              
Beginning balance at Jun. 30, 2020 2,681,010 $ (5,530)   2,090,268 654,930 $ (5,530) (79,774) 2,665,424 $ (5,530) 15,586
Increase (Decrease) in Stockholders' Equity                    
Net income attributable to KLA 1,445,314                  
Other comprehensive income 9,301                  
Net loss attributable to non-controlling interest (1,019)                  
Repurchase of common stock (in shares)     (2,707)              
Repurchase of common stock (644,830)                  
Ending balance (in shares) at Mar. 31, 2021     153,359              
Ending balance at Mar. 31, 2021 3,112,864     2,115,205 1,070,124   (70,473) 3,114,856   (1,992)
Beginning balance (in shares) at Sep. 30, 2020     154,606              
Beginning balance at Sep. 30, 2020 2,762,345     2,072,715 753,915   (79,446) 2,747,184   15,161
Increase (Decrease) in Stockholders' Equity                    
Net income attributable to KLA 457,251       457,251     457,251    
Other comprehensive income 6,742           6,742 6,742    
Net loss attributable to non-controlling interest (268)                 (268)
Net issuance under employee stock plans (in shares)     329              
Net issuance under employee stock plans 15,356     15,356       15,356    
Repurchase of common stock (in shares)     (774)              
Repurchase of common stock (177,492)     (10,477) (167,015)     (177,492)    
Cash dividends and dividend equivalents declared (140,455)       (140,455)     (140,455)    
Stock-based compensation expense 26,827     26,596       26,596   231
Ending balance (in shares) at Dec. 31, 2020     154,161              
Ending balance at Dec. 31, 2020 2,950,306     2,104,190 903,696   (72,704) 2,935,182   15,124
Increase (Decrease) in Stockholders' Equity                    
Net income attributable to KLA 567,496       567,496     567,496    
Other comprehensive income 2,231           2,231 2,231    
Net loss attributable to non-controlling interest (326)                 (326)
Net issuance under employee stock plans (in shares)     104              
Net issuance under employee stock plans (6,674)     (6,674)       (6,674)    
Repurchase of common stock (in shares)     (906)              
Repurchase of common stock (273,441)     (12,431) (261,010)     (273,441)    
Cash dividends and dividend equivalents declared (140,058)       (140,058)     (140,058)    
Stock-based compensation expense 30,327     30,120       30,120   207
Net issuance on exercise of options by non-controlling interest 127                 127
Disposal of non-controlling interest (17,124)                 (17,124)
Ending balance (in shares) at Mar. 31, 2021     153,359              
Ending balance at Mar. 31, 2021 $ 3,112,864     $ 2,115,205 $ 1,070,124   $ (70,473) $ 3,114,856   $ (1,992)